ISRG - Intuitive Surgical Inc
The inventor and dominant provider of robotic-assisted surgery systems, with its da Vinci platform installed in thousands of hospitals globally.
Finlify Score
40.3 / 100
Data Quality
FULL
Penalty
0.0
Sector
Health Care
Close Price
$416.55
+1.34%
52W Range
$396.68 - $603.88
Market Cap
$150.4B
+1.3%Compared to previous day
2026 Q1 Revenue
$2.8B
-3.3%Changes from last reporting quarter
2026 Q1 EPS
$2.28
Diluted shares
Analyst Rating
40 analysts in latest ratings feed
RSI
40.0
40-70 moderate
2Y Range Position
9%
-32.4% from high / +5.0% from low
Beta
1.45
Relative to market benchmark
MACD
0.74
MACD line -8.50 / signal line -9.24
Fundamental Trend
Growth 38.2Financial Health
Quality 77.8Data Quality
FULLValuation Reference
Price Chart
Close price, two-year source window
Finlify Score
AVOID40.3 / 100
Score History
Finlify Score and component trend
Financial Statements
Calendar year view. Figures are estimates only. For official figures, refer to the company website.
| 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | |
|---|---|---|---|---|
| Revenue | $2.8B-3.3% | $2.9B+14.4% | $2.5B+2.7% | $2.4B+8.3% |
| Gross Profit | $1.8B-3.9% | $1.9B+14.6% | $1.7B+2.8% | $1.6B+11.0% |
| Operating Income | $855M-1.0% | $864M+13.8% | $760M+2.2% | $743M+28.6% |
| Net Income | $822M+3.4% | $795M+12.8% | $704M+7.0% | $658M-5.7% |
Columns use the calendar quarter of each reported period end date. QoQ is shown for adjacent company reporting quarters only.
AI Signal
Generated Jun 16, 2026
Finlify's signal for ISRG is AVOID, with a Finlify Score of 40.6 out of 100. This appears to be influenced by weaker Relative Strength and Fundamental Trend scores, despite strong Financial Quality.
Technical
The asset's Relative Strength score is notably low at 8.7/100, which suggests underperformance compared to its peers. Recent price action indicates a negative trend, with a -4.0% return over 20 days and a -14.0% return over 60 days, and the stock is currently -30.7% from its 52-week high.
Fundamentals
The Fundamental Trend score is 38.2/100, indicating some underlying challenges, even though Financial Quality is strong at 77.8/100. Valuation metrics appear elevated, with a P/E ratio of 50.6x and a P/S ratio of 14.3x, which may suggest the asset is priced at a premium. The asset does not currently offer a dividend yield.
Macro Context
The prevailing macro environment, characterized by an elevated CPI YoY of 4.3% and a 10Y Treasury Yield of 4.5%, suggests a higher interest rate and inflationary backdrop. This context could potentially exert pressure on growth-oriented assets, particularly those with high valuation multiples like ISRG.
Key Risks
- The very low Relative Strength score of 8.7/100 and significant recent declines (-14.0% over 60 days) suggest a lack of positive price momentum.
- Valuation multiples, such as a P/E of 50.6x and P/S of 14.3x, appear elevated, which may indicate that the asset is priced at a premium.
- A Fundamental Trend score of 38.2/100 suggests underlying fundamental weaknesses, which could impact future performance.